Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Bought 8.1MM Restricted, sold 1.6MM for Taxes.

<< Previous

Bullboard Posts

Next >>

Comment by mdjbrownon Sep 19, 2023 5:03pm

138 Views

Post# 35644220

RE:RE:RE:Bought 8.1MM Restricted, sold 1.6MM for Taxes.

Really important for folks to understand what Restrictive Stock Units (RSU) are.

They are not purchased like a warrant, right, or regular stock options. They are rewarded to the employee / executive as a form of compensation once they are vested. No money exchanges hands unti they are sold.

Very positive though to see the majority of Labs executives have not sold many RSUs once they were converted into common shares. 4 insider sells since June 2023

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?